MUSK and myasthenia gravis: The longitudinal epitope mapping study in 53 MuSK antibody-positive MG patients by the European group showed that 22.6% of the patients were positive for MuSK CRD antibodies, although they emphasized the MuSK Ig 1 domain as the main immunogenic region (Huijbers et al., 2016).